A double-blind comparison of bupropion and amitriptyline in depressed inpatients. 1983

J Davidson, and R Miller, and J Van Wyck Fleet, and R Strickland, and P Manberg, and S Allen, and R Parrott

Bupropion and amitriptyline were compared in a double-blind study of depressed inpatients. Treatment ranged from 2 to 4 weeks: early responders (Hamilton Depression Scale scores less than 10) were often removed from treatment after 2 or 3 weeks. Twenty-two patients completed treatment with bupropion and 18 with amitriptyline. Doses ranged from 450 to 750 mg/day for bupropion and 75 to 225 mg/day for amitriptyline. Overall, bupropion and amitriptyline were equally effective, as measured by the Hamilton Depression and Anxiety scales, Clinical Global Impressions, Zung Depression scale, and the SCL-90. Differences in the side effect profile and in weight change are described.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011427 Propiophenones Propiophenone (ethyl phenyl ketone, structural formula C6H5COCH2CH3) and its derivatives. They are commonly used in perfumes and pharmaceuticals.
D011569 Psychiatric Status Rating Scales Standardized procedures utilizing rating scales or interview schedules carried out by health personnel for evaluating the degree of mental illness. Factor Construct Rating Scales (FCRS),Katz Adjustment Scales,Lorr's Inpatient Multidimensional Psychiatric Rating Scale,Wittenborn Scales,Edinburgh Postnatal Depression Scale,Mini International Neuropsychiatric Interview
D001835 Body Weight The mass or quantity of heaviness of an individual. It is expressed by units of pounds or kilograms. Body Weights,Weight, Body,Weights, Body
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D003866 Depressive Disorder An affective disorder manifested by either a dysphoric mood or loss of interest or pleasure in usual activities. The mood disturbance is prominent and relatively persistent. Depression, Endogenous,Depression, Neurotic,Depression, Unipolar,Depressive Syndrome,Melancholia,Neurosis, Depressive,Unipolar Depression,Depressions, Endogenous,Depressions, Neurotic,Depressions, Unipolar,Depressive Disorders,Depressive Neuroses,Depressive Neurosis,Depressive Syndromes,Disorder, Depressive,Disorders, Depressive,Endogenous Depression,Endogenous Depressions,Melancholias,Neuroses, Depressive,Neurotic Depression,Neurotic Depressions,Syndrome, Depressive,Syndromes, Depressive,Unipolar Depressions
D004311 Double-Blind Method A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment. Double-Masked Study,Double-Blind Study,Double-Masked Method,Double Blind Method,Double Blind Study,Double Masked Method,Double Masked Study,Double-Blind Methods,Double-Blind Studies,Double-Masked Methods,Double-Masked Studies,Method, Double-Blind,Method, Double-Masked,Methods, Double-Blind,Methods, Double-Masked,Studies, Double-Blind,Studies, Double-Masked,Study, Double-Blind,Study, Double-Masked
D005260 Female Females
D006760 Hospitalization The confinement of a patient in a hospital. Hospitalizations

Related Publications

J Davidson, and R Miller, and J Van Wyck Fleet, and R Strickland, and P Manberg, and S Allen, and R Parrott
September 1981, Pharmacopsychiatria,
J Davidson, and R Miller, and J Van Wyck Fleet, and R Strickland, and P Manberg, and S Allen, and R Parrott
May 1993, Pharmacopsychiatry,
J Davidson, and R Miller, and J Van Wyck Fleet, and R Strickland, and P Manberg, and S Allen, and R Parrott
August 1994, Journal of clinical psychopharmacology,
J Davidson, and R Miller, and J Van Wyck Fleet, and R Strickland, and P Manberg, and S Allen, and R Parrott
June 1995, Psychopharmacology,
J Davidson, and R Miller, and J Van Wyck Fleet, and R Strickland, and P Manberg, and S Allen, and R Parrott
August 1991, The Journal of clinical psychiatry,
J Davidson, and R Miller, and J Van Wyck Fleet, and R Strickland, and P Manberg, and S Allen, and R Parrott
January 1992, Neuropsychobiology,
J Davidson, and R Miller, and J Van Wyck Fleet, and R Strickland, and P Manberg, and S Allen, and R Parrott
April 1980, International journal of clinical pharmacology, therapy, and toxicology,
J Davidson, and R Miller, and J Van Wyck Fleet, and R Strickland, and P Manberg, and S Allen, and R Parrott
January 1972, Psychosomatics,
J Davidson, and R Miller, and J Van Wyck Fleet, and R Strickland, and P Manberg, and S Allen, and R Parrott
December 1997, The Journal of clinical psychiatry,
J Davidson, and R Miller, and J Van Wyck Fleet, and R Strickland, and P Manberg, and S Allen, and R Parrott
March 1996, Acta psychiatrica Scandinavica,
Copied contents to your clipboard!